BACKGROUND: Fetal alcohol spectrum disorder (FASD) is the most common cause of neurobehavioural handicap in North America. Screening for FASD may facilitate diagnosis and hence management of these children. We present a variety of screening tools for the identification of children at risk for FASD. METHODS: We critically reviewed and evaluated published and practiced methods for their potential of screening suspected cases, their epidemiological characteristics (sensitivity, specificity, positive and negative predictive values) [Phase I], as well as their feasibility [Phase II]. RESULTS: The following five tools were selected for the FASD screening toolkit: screening fatty acid ethyl esters in neonatal meconium, the modified Child Behaviour Checklist, Medicine Wheel tool, Asante Centre Probation Officer Tool, and maternal history of drinking and drug use. CONCLUSIONS: The toolkit for FASD screening aims at screening different populations, from the newborns to youth and at-risk mothers. It is anticipated that the toolkit will facilitate diagnosis of FASD.
BACKGROUND:Fetal alcohol spectrum disorder (FASD) is the most common cause of neurobehavioural handicap in North America. Screening for FASD may facilitate diagnosis and hence management of these children. We present a variety of screening tools for the identification of children at risk for FASD. METHODS: We critically reviewed and evaluated published and practiced methods for their potential of screening suspected cases, their epidemiological characteristics (sensitivity, specificity, positive and negative predictive values) [Phase I], as well as their feasibility [Phase II]. RESULTS: The following five tools were selected for the FASD screening toolkit: screening fatty acid ethyl esters in neonatal meconium, the modified Child Behaviour Checklist, Medicine Wheel tool, Asante Centre Probation Officer Tool, and maternal history of drinking and drug use. CONCLUSIONS: The toolkit for FASD screening aims at screening different populations, from the newborns to youth and at-risk mothers. It is anticipated that the toolkit will facilitate diagnosis of FASD.
Authors: Svetlana Popova; Shannon Lange; Larry Burd; Albert E Chudley; Sterling K Clarren; Jürgen Rehm Journal: PLoS One Date: 2013-04-04 Impact factor: 3.240
Authors: Irene Zelner; Kelly Kenna; James F Brien; Alan Bocking; Richard Harding; David Walker; Gideon Koren Journal: PLoS One Date: 2013-03-22 Impact factor: 3.240
Authors: Rochelle E Watkins; Elizabeth J Elliott; Jane Halliday; Colleen M O'Leary; Heather D'Antoine; Elizabeth Russell; Lorian Hayes; Elizabeth Peadon; Amanda Wilkins; Heather M Jones; Anne McKenzie; Sue Miers; Lucinda Burns; Raewyn C Mutch; Janet M Payne; James P Fitzpatrick; Maureen Carter; Jane Latimer; Carol Bower Journal: BMC Pediatr Date: 2013-01-25 Impact factor: 2.125
Authors: Rochelle E Watkins; Elizabeth J Elliott; Amanda Wilkins; Raewyn C Mutch; James P Fitzpatrick; Janet M Payne; Colleen M O'Leary; Heather M Jones; Jane Latimer; Lorian Hayes; Jane Halliday; Heather D'Antoine; Sue Miers; Elizabeth Russell; Lucinda Burns; Anne McKenzie; Elizabeth Peadon; Maureen Carter; Carol Bower Journal: BMC Pediatr Date: 2013-10-02 Impact factor: 2.125
Authors: Rochelle E Watkins; Elizabeth J Elliott; Amanda Wilkins; Jane Latimer; Jane Halliday; James P Fitzpatrick; Raewyn C Mutch; Colleen M O'Leary; Lucinda Burns; Anne McKenzie; Heather M Jones; Janet M Payne; Heather D'Antoine; Sue Miers; Elizabeth Russell; Lorian Hayes; Maureen Carter; Carol Bower Journal: BMC Pediatr Date: 2014-07-08 Impact factor: 2.125